Schizophrenia Flashcards
Schizophrenia - genetic concordance rate with twin and relative and lifetime risk
monogenetic twins: 50%
first degree relative: 10%
lifetime risk: 1%
Genetic Contributions to SZ
Common variation
Rare copy number variants
Rare sequence variants
What are copy number variants?
Copy number variation (CNV) is a general term used to describe a molecular phenomenon in which SEQUENCES OF THE GENOME ARE REPEATED, and the number of repeats varies between individuals of the same species.
Copy number variants in SZ
- can be deletions
- can be duplications
There are regions more susceptible to these but they are overall rare.
NRXN1 deletion seems to be the only related CNV.
Types of DNA change that alter amino acids
- nonsense (stop) variant
- frame shift mutation
- splice-site mutation
what is a synonymous variant
change to DNA that gives the same amino acid.
nonsense (stop) variant
change to DNA that introduces a STOP codon
frame shift mutation
change to DNA that add/removes
splice-site mutation
change to DNA that will not introduce intron or not include exon.
High impact coding variants in SZ
- Loss of function (LoF) variants / protein truncating variants (PTV): stop-gained, frameshift, splice site.
- Damaging missense: nonsynonymous variants with high score using missense badness, polyphen-2 and constraint (MPC) pathogenicity classifier.
SZ and SETD1A
SETD1A loss of function are very rare variants, that are implicated in SZ.
There are 10 different LoF variants in SETD1A in SZ.
SETD1A codes for a methyl trasnferase for HISTONE H3.
what did the SCHEMA study for SZ find:
FOUND: SZ risk higher in carriers of protein truncating (LOF) or missense (MPC>3) variants in LOF-intolerant genes.
- Identified ten genes, incl. GRIN2A, SP4, and SETD1A, in which rare coding variants increase risk.
These were extremely rare.
SETD1A mouse model
SETD1A LoF variant - methylates H3K4 lysine.
These mice have abnormal architecture and subtle cognitive deficits
Treatment with Tranylcypromine (TCP) restores SETD1A deficient mice to normal functioning.
GRIN2A and SP4 and SZ risk
GRIN2A codes for subunit of NMDAR receptor
SP4 required for expression of GRIN1, which codes for another subunit of NMDAR.
SO - NMDAR as a drug target
NMDAR as a drug target
can be enhanced by SARCOSINE.
small molecules can also target NMDAR to enhance function.
- Small molecules which are LSD1 inhibitors (balancing SETD1A hypofunction)
- Lipid nanoparticles to deliver mRNA for GRIN2A or GRIA3 (glutamate receptor genes